DIFFERENTIATED THYROID CANCER
Clinical trials for DIFFERENTIATED THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new DIFFERENTIATED THYROID CANCER trials appear
Sign up with your email to follow new studies for DIFFERENTIATED THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Pre-Surgery drug improve thyroid cancer outcomes?
Disease control CompletedThis study tested whether giving the drug lenvatinib before surgery helps remove advanced thyroid cancer more completely. 29 adults with invasive thyroid cancer took lenvatinib for a short time before their operation. The goal was to see if more patients could have clear or nearl…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for tough thyroid cancers? cabozantinib trial shows promise
Disease control CompletedThis study tested the drug cabozantinib in 41 adults with advanced differentiated thyroid cancer that no longer responds to radioactive iodine treatment. Participants took a 60 mg pill daily until their cancer worsened or side effects became too severe. The main goal was to under…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Lenvatinib under the microscope: safety check for tough thyroid cancers
Disease control CompletedThis study looked at the safety of the drug lenvatinib in 50 people with advanced thyroid cancer that had stopped responding to radioactive iodine treatment. Researchers tracked side effects and how often patients needed to lower their dose. They also checked whether tumors shran…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE4 • Sponsor: Eisai Pharmaceuticals India Pvt. Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for Hard-to-Treat thyroid cancer: experimental drug shows promise
Disease control CompletedThis early-phase trial tested an experimental drug called AL2846 in 33 people with a type of thyroid cancer that no longer responds to standard treatments. The goal was to see if the drug could shrink tumors or slow the cancer's growth. Participants took the drug by mouth, and do…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Minutes, not days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedThis study tested a new rapid test that checks for thyroid cancer spread to neck lymph nodes in just minutes, instead of the usual days-long wait. Researchers studied 250 adults with suspected or known thyroid cancer, comparing the quick test to standard lab methods. The goal was…
Matched conditions: DIFFERENTIATED THYROID CANCER
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Radiation safety study aims to personalize thyroid cancer treatment
Knowledge-focused CompletedThis study collects standard-of-care images from people with differentiated thyroid cancer who are treated with radioactive iodine (Iodine-131). The goal is to better understand how much radiation reaches healthy organs and what dose is needed to destroy thyroid tissue. By gather…
Matched conditions: DIFFERENTIATED THYROID CANCER
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC